COMMUNIQUÉS West-GlobeNewswire
-
Liv Hospital Highlights Hospital-Based Stem Cell Infrastructure During Autism Awareness Month
02/04/2026 -
Curonix LLC Announces Expanded Reimbursement Coverage for Freedom® Peripheral Nerve Stimulator (PNS) System, Providing Access To An Additional 27 Million Covered Lives Nationwide
02/04/2026 -
BioCardia Files Request for Meeting With FDA to Discuss Accelerated Approval Pathway for CardiAMP® System in Ischemic Heart Failure
02/04/2026 -
GENFIT : Résultats financiers annuels 2025 et point sur les activités de la Société
02/04/2026 -
EssilorLuxottica entre au capital de Top Charoen pour renforcer sa présence en Thailande
02/04/2026 -
AbbVie IBD Scholarship Program Marks 15 Years: Applications Open for 2026
02/04/2026 -
Medicana Health Group Marks World Autism Awareness Day with a Call for Inclusion, Earlier Recognition and Family-Centered Support
02/04/2026 -
EssilorLuxottica acquires a stake in Top Charoen, reinforcing its presence in Thailand
02/04/2026 -
EYLEA HD® (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF with Dosing Intervals Up to 5 Months for Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME)
02/04/2026 -
GENFIT Reports Full-Year 2025 Financial Results and Provides Corporate Update
02/04/2026 -
Le programme de bourses d'études MII d’AbbVie fête ses 15 ans : les candidatures sont ouvertes pour 2026
02/04/2026 -
Visory Health Ranks Among Top U.S. Prescription Cards Providing Millions of Americans Access to Affordable Medications
02/04/2026 -
Catalyst MedTech Announces Acquisition of X3D
02/04/2026 -
Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership
02/04/2026 -
MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new board member
02/04/2026 -
PracticeLink Reveals Evolved Brand Identity Focused on Clarity, Simplicity and Trust for Healthcare Providers and Recruiters
02/04/2026 -
Protecting Healthy Futures: Unity Consortium Urges Families to Prioritize Adolescent Health During Immunization Action Week
02/04/2026 -
Ultragenyx Announces U.S. FDA Acceptance of BLA Resubmission for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)
02/04/2026 -
Sienna Announces First Quarter 2026 Results Release Date and Conference Call
02/04/2026
Pages